Marla Klein
Portland, ORNPI 1912990664
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.0%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 66.8% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2021 at $3,099 and has fallen 65.8% since, to $1,060 in 2025.
Across 329 payments — averaging $34.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Johnson & Johnson$780
- Lilly USA, LLC$431
- Galderma Laboratories, L.p.$383
- E.r. Squibb & Sons, L.L.C.$309
- Novartis$216
- plus $2K from 18 others
What the payments were for
- Speaking & faculty fees$5,86151%
- Food & beverage$5,32146%
- Education$3083%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 143 | $7,679 |
| Johnson & Johnson(2 entities) | 32 | $780 |
| Lilly USA, LLC | 23 | $431 |
| Galderma Laboratories, L.p. | 18 | $383 |
| E.r. Squibb & Sons, L.L.C. | 13 | $309 |
| Novartis | 10 | $216 |
| Sanofi | 9 | $199 |
| Biofrontera Inc. | 15 | $157 |
| Amgen | 7 | $142 |
| Pfizer | 7 | $141 |
| Arcutis Biotherapeutics, Inc. | 7 | $129 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $125 |
| Dermavant Sciences, Inc. | 4 | $114 |
| Incyte Corporation | 5 | $108 |
| Sun Pharmaceutical Industries Inc. | 4 | $97 |
| Almirall LLC | 4 | $90 |
| LEO Pharma Inc. | 4 | $74 |
| Revance Therapeutics, Inc. | 2 | $65 |
| Mayne Pharma Commercial LLC | 4 | $62 |
| Dermira, Inc. | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 4 | $59 |
| Bristol Myers Squibb | 2 | $39 |
| UCB, Inc. | 1 | $21 |
| Organon | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$128
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 11 | $174 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.